Échelles fonctionnelles de la sclérose latérale amyotrophique

Appel, 1987, A rating scale for amyotrophic lateral sclerosis: description and preliminary experience, Ann Neurol, 22, 328, 10.1002/ana.410220308 ALS CNTF Treatment Study (ACTS) Study Group (1996). A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (r HCNTF) in amyotrophic lateral sclerosis. Neurology, 46 1244-1249. Borg, 1990, Psychophysical scaling with applications in physical work and the perception of exertion, Scand J Work Environ Health, 16, 55, 10.5271/sjweh.1815 Brinckmann, 1997, Guidelines for the use and performance of quantitative outcome measure in ALS clinical trials, J Neurol Sci, 147, 97, 10.1016/S0022-510X(96)05220-3 Brooks, 1991, Design of clinical therapeutic trials in amyotrophic lateral sclerosis, Adv Neurol, 56, 521 Brooks B.R. Rose F.C. The Norris ALS score: insight into the natural history of amyotrophic lateral sclerosis provided by Forbes Norris Amyotrophic Lateral Sclerosis, III : ALS-from Charcot to the Present and into the Future Smith London 1994 21- 29 Brooks, 1997, Amyotrophic lateral sclerosis clinimetric scales: guidelines for administration and scoring Cedarbaum, 1999, The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function, J Neurol Sci, 169, 13, 10.1016/S0022-510X(99)00210-5 Desnuelle, 2001, A double-blind, placebo-controlled randomized study of α-tocopherol in the treatment of amyotrophic lateral sclerosis, ALS, 2, 9, 10.1080/146608201300079364 Gordon, 2004, ALSFRS-R. ALSα Other Motor, Neuron Disord, 5, 90 Guiloff, 1987, Observations on the clinical assessment of patients with motor neuron disease, Neurol Clin, 5, 171, 10.1016/S0733-8619(18)30941-1 Hillel, 1990, Amyotrophic lateral sclerosis severity scale Honda, 1990, Clinical appraisal of progression of amyotrophic lateral sclerosis: a Japanese ALS Scale Johns, 1991, A new method for measuring daytime sleepiness: the Epworth sleepiness scale, Sleep, 14, 540, 10.1093/sleep/14.6.540 Kasarskis, 2005, Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R, ALS & Other Motor Neuron Disord, 1, 50, 10.1080/14660820510027107 Kent, 1992, Quantitative description of the dysathria in women with ALS, J Speech Hearing Res, 35, 723, 10.1044/jshr.3504.723 Lacomblez, 1996, Dose-ranging study of riluzole in amyotrophic lateral sclerosis, Lancet, 347, 1425, 10.1016/S0140-6736(96)91680-3 Lange, 1995, Experience with myotrophin Lange, 1994, A double-blind placebo-controlled study to assess the effects of deprenyl on the clinical course of ALS, Neurology, 44, A256 Louwerse, 1990, Critique of assessment methodology in amyotrophic lateral sclerosis Miller, 2001, Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis, Neurology, 56, 843, 10.1212/WNL.56.7.843 Mitsumoto, 1998, Treatment trials in Amyotrophic Lateral Sclerosis Munsat, 1996, Development of measurement techniques, Neurology, 47, S83, 10.1212/WNL.47.4_Suppl_2.83S Norris, 1979, Trial of baclofen in amyotrophic lateral sclerosis, Arch Neurol, 36, 715, 10.1001/archneur.1979.00500470085019 Olarte, 1985, Levamisole is ineffective in the treatment of amyotrophic lateral sclerosis, Neurology, 35, 1063, 10.1212/WNL.35.7.1063 Rivière, 1998, An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole, Arch Neurol, 55, 526, 10.1001/archneur.55.4.526 Sadoul, 1983, Assessment of functional respiratory deficit Bull, Eur Physiopathol Respir, 9, 3 1996, The Amyotrophic lateral sclerosis functional rating scale: Assessment of activities of daily living in patients with amyotrophic lateral sclerosis, Arch Neurol, 53, 141, 10.1001/archneur.1996.00550020045014 1993, Branched-chain amino acids and amyotrophic lateral sclerosis: A treatment failure?, Neurology, 43, 2466, 10.1212/WNL.43.12.2466